Onjixanthone I exhibits significant potential in pharmaceutical applications, particularly in anticancer research. It demonstrates cytotoxic activity against certain tumor cell lines, making it a candidate for development in oncology therapeutics. Studies suggest it may interfere with cell proliferation and induce apoptosis in cancer cells through modulation of key signaling pathways. Its natural origin and unique xanthone structure contribute to its bioactivity, supporting interest in its use as a lead compound for drug discovery. Additionally, Onjixanthone I has shown antimicrobial properties, indicating possible utility in treating microbial infections. Further research is focused on optimizing its efficacy and understanding its mechanism of action for therapeutic applications.